![Rafal Goraczniak](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Rafal Goraczniak
Gründer bei Ceptur Therapeutics, Inc.
Aktive Positionen von Rafal Goraczniak
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Silagene, Inc.
![]() Silagene, Inc. Medical/Nursing ServicesHealth Services Silagene, Inc. provides health care services. The company is headquartered in Hillsborough, NJ. | Direktor/Vorstandsmitglied | - | - |
Ceptur Therapeutics, Inc.
![]() Ceptur Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Ceptur Therapeutics, Inc. is a company that focuses on developing medicines for severe diseases in the areas of oncology, the central nervous system, nephrology, and immunology. The company is based in Hillsborough, NJ and has subsidiaries in the United States. The company is revolutionizing RNA therapeutics with U1 adaptor technology to address unaddressed diseases. The company was founded by Rafal Goraczniak and P. Peter Ghoroghchian, with P. Peter Ghoroghchian serving as CEO since incorporation. | Gründer | - | - |
Corporate Officer/Principal | - | - |
Karriereverlauf von Rafal Goraczniak
Statistik
International
Vereinigte Staaten | 3 |
Operativ
Director/Board Member | 1 |
Founder | 1 |
Corporate Officer/Principal | 1 |
Sektoral
Health Services | 2 |
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Silagene, Inc.
![]() Silagene, Inc. Medical/Nursing ServicesHealth Services Silagene, Inc. provides health care services. The company is headquartered in Hillsborough, NJ. | Health Services |
Ceptur Therapeutics, Inc.
![]() Ceptur Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Ceptur Therapeutics, Inc. is a company that focuses on developing medicines for severe diseases in the areas of oncology, the central nervous system, nephrology, and immunology. The company is based in Hillsborough, NJ and has subsidiaries in the United States. The company is revolutionizing RNA therapeutics with U1 adaptor technology to address unaddressed diseases. The company was founded by Rafal Goraczniak and P. Peter Ghoroghchian, with P. Peter Ghoroghchian serving as CEO since incorporation. | Health Technology |
- Börse
- Insiders
- Rafal Goraczniak
- Erfahrung